Skip to main content
Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
2.080
-0.120 (-5.45%)
Nov 21, 2024, 12:02 PM EST - Market open

Edesa Biotech Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
16
Market Cap
6.75M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 2023---
Sep 30, 2022---
Sep 30, 2021---
Sep 30, 2020328.80K-82.07K-19.97%
Sep 30, 2019410.87K--
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ATI Physical Therapy 728.11M
Evoke Pharma 8.62M
Plus Therapeutics 5.73M
Addex Therapeutics 960.64K
ABVC BioPharma 509.79K
BioCardia 71.00K
Cardio Diagnostics Holdings 35.69K
Revenue Rankings

EDSA News

More News